Last reviewed · How we verify

NCT04213040

Procalcitonin and Postoperative Outcome After Open-heart Surgery

Completed Last updated 13 February 2020
What this trial tests

trial testing Serum levels of Procalcitonin, C-reactive protein, lactate in Open Heart Surgery in 214 participants. Completed in 31 December 2013.

Timeline
1 January 2013
Primary endpoint
31 July 2013
31 December 2013

Quick facts

Lead sponsorKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment214
Start date1 January 2013
Primary completion31 July 2013
Estimated completion31 December 2013

Drugs / interventions tested

Conditions studied

Sponsor

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

Who can join

Adults 19 to 80, any sex, with Open Heart Surgery or Cardiopulmonary Bypass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the impact of serum values of procalcitonin (PCT), C-reactive protein (CRP) and lactate to predict postoperative complications in the early postoperative period after open-heart surgery with cardiopulmonary bypass (CPB).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Open Heart Surgery

Currently open trials in the same condition.

Other Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04213040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing